BRK-B vs CVCO: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CVCO is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BRK-B and CVCO share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BRK-B and CVCO exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Berkshire Hathaway is a diversified holding company that owns a wide range of businesses outright and holds a large portfolio of public stocks. Its foundation is insurance: GEICO, Berkshire Hathaway Reinsurance, and other insurers generate underwriting profit and, more importantly, float (premiums held before claims are paid) that Berkshire invests. In Q1 2026 insurance underwriting income rose to about $1.72 billion from $1.34 billion a year earlier, and Q2 2026 underwriting income was about $1.73 billion. Insurance float stood at about $177.5 billion at June 30, 2026. Beyond insurance, Berkshire owns the BNSF railroad, Berkshire Hathaway Energy, and consumer and industrial businesses such as Duracell, Dairy Queen, See's Candies, and Precision Castparts, alongside a stock portfolio historically anchored by names like Apple and American Express. Under Abel the operating group has kept growing by acquisition: Berkshire completed its purchase of OxyChem on January 2, 2026 and closed the $8.5 billion acquisition of homebuilder Taylor Morrison on July 24, 2026.

Full BRK-B guide

Cavco Industries designs and builds factory-built homes (manufactured homes, modular homes, and commercial and park-model structures) across roughly 33 production lines, distributing through about 92 company-owned retail stores plus a network of independent retailers. Beyond building homes, it runs two financial-services arms: CountryPlace Mortgage, which originates and services home-only (chattel) and land-home mortgages, and Standard Casualty, an insurance subsidiary covering manufactured homes. That vertically integrated model lets Cavco capture margin across construction, distribution, financing, and insurance.

Full CVCO guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BRK-B drivers: Leadership transition to Greg Abel; Insurance float and underwriting.
• CVCO drivers: Structural affordability tailwind; Fortress balance sheet and buybacks.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The central 2026 risk is the leadership transition itself, now complete at the top with Buffett as chairman emeritus: Buffett's judgment and reputation were core to Berkshire's edge, and the market will test whether Greg Abel can allocate capital as effectively, especially with a record cash pile to deploy. For CVCO, demand is highly sensitive to interest rates because many buyers rely on chattel (home-only) loans that carry higher rates than traditional mortgages, so elevated rates directly dampen affordability and orders.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BRK-B if you believe its drivers more; CVCO if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BRK-B and CVCO guides.

BRK-B. Figures are approximate and tied to mid-October 2026; verify live numbers before acting. Because accounting rules force Berkshire to mark its large stock portfolio to market each quarter, GAAP net income is noisy: the trailing P/E of about 13 is flattered by investment gains, while the forward multiple of about 24 is based on operating earnings alone. The cash balance means a meaningful part of the market cap is cash awaiting deployment, and the resumption of buybacks in 2026 suggests management sees the shares as reasonably priced. Third-quarter results are expected around November 7, 2026.

CVCO. At about $528 per share the market cap is roughly $4.1 billion, a trailing P/E near 23x and a forward P/E near 18x, still a premium to typical homebuilders. The premium reflects the net-cash balance sheet and consistent returns, but with earnings drifting lower in recent quarters the multiple now leans on the expected fiscal 2028 rebound. The October 29 fiscal Q2 report (consensus EPS about $5.38 on revenue near $613 million) is the next read on margins.

Headline figures (approximate, October 2026): BRK-B shows operating earnings (q2 2026) ~$12.98 billion, up ~16% from ~$11.16 billion; first half ~$24.3 billion, net earnings (q2 2026) ~$25.7 billion, including ~$12.7 billion of investment gains from equity marks, revenue (ttm) ~$385 billion; Q2 2026 revenue up ~10% year over year, insurance float ~$177.5 billion at June 30, 2026; CVCO shows revenue (ttm) ~$2.30B (latest quarter up ~10% YoY), net income (ttm) ~$181M (profit margin ~7.9%), gross margin (ttm) ~21.9%, eps (trailing / fiscal 2028 est.) ~$22.99 / ~$28.82.

BRK-B and CVCO are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BRK-B and CVCO exposure against your real portfolio. It is not an investment adviser.